BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/10/2022 9:43:36 AM | Browse: 838 | Download: 2096
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 65491
Country United States
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Review
Article Title Gut microbiome in non-alcoholic fatty liver disease associated hepatocellular carcinoma: Current knowledge and potential for therapeutics
Manuscript Source Invited Manuscript
All Author List Imaad Said, Hassan Ahad and Adnan Said
ORCID
Author(s) ORCID Number
Imaad Said http://orcid.org/0000-0002-7126-3794
Hassan Ahad http://orcid.org/0000-0002-2527-6308
Adnan Said http://orcid.org/0000-0001-9944-4071
Funding Agency and Grant Number
Corresponding Author Adnan Said, FAASLD, MD, MS, Associate Professor, Division of Gastroenterology and Hepatology, Department of Medicine, William S. Middleton VAMC, University of Wisconsin School of Medicine and Public Health, 4223 MFCB, 1685 Highland Avenue, Madison, WI 53705, United States. axs@medicine.wisc.edu
Key Words Microbiome; Gut microbiome; Hepatocellular carcinoma; Nonalcoholic fatty liver disease; Pathophysiology; Treatment
Core Tip The gut microbiome is intimately linked to nonalcoholic fatty liver disease, cirrhosis and hepatocellular carcinoma. The breakdown of the intestinal barrier in liver disease, innate immune system stimulation and bile acid profile changes are increasingly found in association with these diseases. Manipulation of the microbiome by diet, probiotics, prebiotics and other agents is a promising area of investigation.
Publish Date 2022-05-10 09:43
Citation Said I, Ahad H, Said A. Gut microbiome in non-alcoholic fatty liver disease associated hepatocellular carcinoma: Current knowledge and potential for therapeutics. World J Gastrointest Oncol 2022; 14(5): 947-958
URL https://www.wjgnet.com/1948-5204/full/v14/i5/947.htm
DOI https://dx.doi.org/10.4251/wjgo.v14.i5.947
Full Article (PDF) WJGO-14-947.pdf
Full Article (Word) WJGO-14-947.docx